The novel treatment of the medication represents a exciting advance in the management of diabetes mellitus type 2. Unlike existing medications, tirzepatide affects two pathways – the GLP-1 hormone and the GIP hormone https://tirzepatidepeptide691077.fitnell.com/83135895/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment